Comparing reliability of ICD-10-based COVID-19 comorbidity data to manual chart review, a retrospective cross-sectional study

J Med Virol. 2022 Apr;94(4):1550-1557. doi: 10.1002/jmv.27492. Epub 2021 Dec 8.

Abstract

International Statistical Classification of Disease and Related Health Problems, 10th Revision codes (ICD-10) are used to characterize cohort comorbidities. Recent literature does not demonstrate standardized extraction methods.

Objective: Compare COVID-19 cohort manual-chart-review and ICD-10-based comorbidity data; characterize the accuracy of different methods of extracting ICD-10-code-based comorbidity, including the temporal accuracy with respect to critical time points such as day of admission.

Design: Retrospective cross-sectional study.

Measurements: ICD-10-based-data performance characteristics relative to manual-chart-review.

Results: Discharge billing diagnoses had a sensitivity of 0.82 (95% confidence interval [CI]: 0.79-0.85; comorbidity range: 0.35-0.96). The past medical history table had a sensitivity of 0.72 (95% CI: 0.69-0.76; range: 0.44-0.87). The active problem list had a sensitivity of 0.67 (95% CI: 0.63-0.71; range: 0.47-0.71). On day of admission, the active problem list had a sensitivity of 0.58 (95% CI: 0.54-0.63; range: 0.30-0.68)and past medical history table had a sensitivity of 0.48 (95% CI: 0.43-0.53; range: 0.30-0.56).

Conclusions and relevance: ICD-10-based comorbidity data performance varies depending on comorbidity, data source, and time of retrieval; there are notable opportunities for improvement. Future researchers should clearly outline comorbidity data source and validate against manual-chart-review.

Keywords: COVID-19; International Classification of Diseases; comorbidity; electronic health records; research design.

Publication types

  • Comparative Study
  • Validation Study

MeSH terms

  • COVID-19 / diagnosis*
  • COVID-19 / epidemiology
  • COVID-19 / virology
  • Clinical Coding / methods
  • Clinical Coding / standards*
  • Comorbidity
  • Cross-Sectional Studies
  • Female
  • Humans
  • International Classification of Diseases / standards*
  • Male
  • Middle Aged
  • Philadelphia
  • Reproducibility of Results
  • Retrospective Studies
  • SARS-CoV-2